Skip to main content

Tricuspid Valve Disease clinical trials at UCSF

2 research studies open to eligible people

Tricuspid valve disease is a condition that affects the tricuspid valve in the heart. UCSF is conducting clinical trials to evaluate new treatments for tricuspid valve disease. One trial is testing the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system. Another trial is investigating the Edwards PASCAL Transcatheter Repair System for patients with severe tricuspid regurgitation.

Showing trials for
  • Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

    open to eligible people ages 18 years and up

    To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

    San Francisco, California and other locations

  • TRISCEND II Pivotal Trial

    open to eligible people ages 18 years and up

    Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system

    San Francisco, California and other locations

Our lead scientists for Tricuspid Valve Disease research studies include .

Last updated: